• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    367.24 Feb 11, 4:00PM EST
    Prev Close:367.24
    Open:N/A
    Bid:367.24 x 100
    Ask:385.00 x 100
    1y Target Est:587.90
    Beta:1.80611
    Earnings Date:May 5 - May 9 (Est.)
    Day's Range:N/A - N/A
    52wk Range:350.26 - 605.93
    Volume:0
    Avg Vol (3m):868,044
    Market Cap:38.94B
    P/E (ttm):72.53
    EPS (ttm):5.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    REGN 0.00%38.94B
    AMGN106.66B

    Key Statistics

    Forward P/E (1 yr):30.53
    P/S (ttm):9.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :12.57
    Quarterly EPS Est (Dec-15) :3.36
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):1.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback